Clinical Trial Update: Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating rituximab in treating follicular non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Lymphoma | Phase 3 | Status: COMPLETED